TORONTO, ONTARIO--(Marketwire - November 30, 2008) - PharmEng International Inc. (TSX VENTURE: PII), a full-service consulting and contract manufacturing company, today reported its results for the period ended September 30, 2008. The Company also announced Board changes and provided an update on the strategic plan involving the integration of the newly commissioned Sydney facility. Readers are encouraged to review the Company’s complete Interim Consolidated Financial Statements and accompanying Management’s Discussion & Analysis which are available under the “investors” section of its website at www.pharmeng.com and on SEDAR at www.sedar.com.
